These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 28222789)
1. Is CCNU (lomustine) valuable for treatment of cutaneous epitheliotropic lymphoma in dogs? A critically appraised topic. Laprais A; Olivry T BMC Vet Res; 2017 Feb; 13(1):61. PubMed ID: 28222789 [TBL] [Abstract][Full Text] [Related]
2. Response of canine cutaneous epitheliotropic lymphoma to lomustine (CCNU): a retrospective study of 46 cases (1999-2004). Risbon RE; de Lorimier LP; Skorupski K; Burgess KE; Bergman PJ; Carreras J; Hahn K; Leblanc A; Turek M; Impellizeri J; Fred R; Wojcieszyn JW; Drobatz K; Clifford CA J Vet Intern Med; 2006; 20(6):1389-97. PubMed ID: 17186855 [TBL] [Abstract][Full Text] [Related]
3. CCNU in the treatment of canine epitheliotropic lymphoma. Williams LE; Rassnick KM; Power HT; Lana SE; Morrison-Collister KE; Hansen K; Johnson JL J Vet Intern Med; 2006; 20(1):136-43. PubMed ID: 16496933 [TBL] [Abstract][Full Text] [Related]
5. Outcomes and prognostic factors in canine epitheliotropic and nonepitheliotropic cutaneous T-cell lymphomas. Azuma K; Ohmi A; Goto-Koshino Y; Tomiyasu H; Ohno K; Chambers JK; Uchida K; Namba H; Nagata M; Nagamine E; Nibe K; Irie M; Tsujimoto H Vet Comp Oncol; 2022 Mar; 20(1):118-126. PubMed ID: 34250731 [TBL] [Abstract][Full Text] [Related]
6. Lomustine (CCNU) for the treatment of resistant lymphoma in dogs. Moore AS; London CA; Wood CA; Williams LE; Cotter SM; L'Heureux DA; Frimberger AE J Vet Intern Med; 1999; 13(5):395-8. PubMed ID: 10499719 [TBL] [Abstract][Full Text] [Related]
7. Combination of CCNU and DTIC chemotherapy for treatment of resistant lymphoma in dogs. Flory AB; Rassnick KM; Al-Sarraf R; Bailey DB; Balkman CE; Kiselow MA; Autio K J Vet Intern Med; 2008; 22(1):164-71. PubMed ID: 18289305 [TBL] [Abstract][Full Text] [Related]
9. Comparison between L-CHOP and an L-CHOP protocol with interposed treatments of CCNU and MOPP (L-CHOP-CCNU-MOPP) for lymphoma in dogs. Rassnick KM; Bailey DB; Malone EK; Intile JL; Kiselow MA; Flory AB; Barlow LL; Balkman CE; Barnard SM; Waite AH Vet Comp Oncol; 2010 Dec; 8(4):243-53. PubMed ID: 21062406 [TBL] [Abstract][Full Text] [Related]
10. Treatment of canine mast cell tumors with CCNU (lomustine). Rassnick KM; Moore AS; Williams LE; London CA; Kintzer PP; Engler SJ; Cotter SM J Vet Intern Med; 1999; 13(6):601-5. PubMed ID: 10587263 [TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy with continuous L-asparaginase, lomustine, and prednisone for relapsed canine lymphoma. Saba CF; Hafeman SD; Vail DM; Thamm DH J Vet Intern Med; 2009; 23(5):1058-63. PubMed ID: 19678892 [TBL] [Abstract][Full Text] [Related]
12. Chemotherapy and radiotherapy for treatment of cutaneous lymphoma in a ground cuscus (Phalanger gymnotis). Goodnight AL; Couto CG; Green E; Barrie M; Myers G J Zoo Wildl Med; 2008 Sep; 39(3):472-5. PubMed ID: 18817015 [TBL] [Abstract][Full Text] [Related]
13. Comparison of 3 protocols for treatment after induction of remission in dogs with lymphoma. Rassnick KM; McEntee MC; Erb HN; Burke BP; Balkman CE; Flory AB; Kiselow MA; Autio K; Gieger TL J Vet Intern Med; 2007; 21(6):1364-73. PubMed ID: 18196748 [TBL] [Abstract][Full Text] [Related]
14. Tolerability of lomustine in combination with cyclophosphamide in dogs with lymphoma. Rassnick KM; Bailey DB; Malone EK; Flory AB; Kiselow MA; Intile JL J Am Anim Hosp Assoc; 2014; 50(3):167-73. PubMed ID: 24659727 [TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy with L-asparaginase, lomustine, and prednisone for relapsed or refractory canine lymphoma. Saba CF; Thamm DH; Vail DM J Vet Intern Med; 2007; 21(1):127-32. PubMed ID: 17338160 [TBL] [Abstract][Full Text] [Related]
16. Lomustine and prednisone as a first-line treatment for dogs with multicentric lymphoma: 17 cases (2004-2005). Sauerbrey ML; Mullins MN; Bannink EO; Van Dorp TE; Kaneene JB; Obradovich JE J Am Vet Med Assoc; 2007 Jun; 230(12):1866-9. PubMed ID: 17571992 [TBL] [Abstract][Full Text] [Related]
17. Clinical outcome and prognosis of dogs with histopathological features consistent with epitheliotropic lymphoma: a retrospective study of 148 cases (2003-2015). Chan CM; Frimberger AE; Moore AS Vet Dermatol; 2018 Apr; 29(2):154-e59. PubMed ID: 28983988 [TBL] [Abstract][Full Text] [Related]
18. Clinical response to isotretinoin and interferon-α of two dogs with cutaneous epitheliotropic T-cell lymphoma: a case report. Lee GW; Song SB; Kang MH; Park HM BMC Vet Res; 2018 Dec; 14(1):382. PubMed ID: 30514314 [TBL] [Abstract][Full Text] [Related]
19. LOPP chemotherapy as a first-line treatment for dogs with T-cell lymphoma. Brown PM; Tzannes S; Nguyen S; White J; Langova V Vet Comp Oncol; 2018 Mar; 16(1):108-113. PubMed ID: 28508557 [TBL] [Abstract][Full Text] [Related]
20. Combination CCNU and vinblastine chemotherapy for canine mast cell tumours: 57 cases. Cooper M; Tsai X; Bennett P Vet Comp Oncol; 2009 Sep; 7(3):196-206. PubMed ID: 19691648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]